News & Analysis on Clinical Trial Services & Contract Research And Development
Gamma Biosciences: production facility at Penn State
By Jenni Spinner
- Last updated on
Gamma BioSciences has announced its cell-selection and bioseparation company BioMagnetic Solutions has signed an agreement do build a production facility at Penn State’s Innovation Park. With an anticipated open date in mid-2022, the facility will feature more than 13,000 square feet of cGMP manufacturing, laboratory, and office space.
Gamma Biosciences chief technical officer Phil Vanek said, “When we connected with the Innovation Park and the Center of Excellence in Industrial Biotechnology teams at Penn State, we knew we had found the right location to work on developing this game-changing technology while also contributing to this thriving ecosystem to support education and innovation.”